Amphastar Pharmaceuticals, Inc.
NASDAQ: AMPH0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yongfeng Zhang
- Employees
- 2,028
- Headquarters
- Rancho Cucamonga, United States
- IPO year
- 2014
- Market cap
- $926.8M
- Website
- https://www.amphastar.com
Loading AMPH…
Loading profile data…Frequently asked questions about AMPH
What does Amphastar Pharmaceuticals, Inc. (AMPH) do?
Amphastar Pharmaceuticals, Inc., established in 1996 and based in Rancho Cucamonga, California, functions as a biopharmaceutical enterprise. The company is engaged in the creation, production, commercialization, and distribution of both generic and proprietary pharmaceutical products, which include injectables, inhalants, and intranasal formulat...
Where does AMPH trade?
Amphastar Pharmaceuticals, Inc. (AMPH) trades on the NASDAQ Global Select.
What sector is AMPH in?
Amphastar Pharmaceuticals, Inc. (AMPH) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Amphastar Pharmaceuticals, Inc.?
Yongfeng Zhang is the chief executive officer of Amphastar Pharmaceuticals, Inc. (AMPH).
Where is Amphastar Pharmaceuticals, Inc. headquartered?
Amphastar Pharmaceuticals, Inc. is headquartered in United States.
Does AMPH pay a dividend?
Amphastar Pharmaceuticals, Inc. (AMPH) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AMPH go public?
Amphastar Pharmaceuticals, Inc. (AMPH) completed its initial public offering in 2014.